Neuravi has announced €15 million in venture debt financing from IPF Partners, a leading alternative financing provider focused on the healthcare sector.
A higher neighbourhood advantage, or socioeconomic status, of where a person lives contributes to a lower risk of having a stroke no matter the person’s race, according to findings published in an online issue of Neurology, the medical journal of the American Academy of Neurology.
Stroke patients are starting a trial of a new electronic device to recover movement and control of their hand. Neuroscientists at Newcastle University, UK, have developed the device, the size of a mobile phone, which delivers a series of small electrical shocks followed by an audible click to strengthen brain and spinal connections.
Researchers have developed a first-of-its-kind tool to help predict a person’s chance of survival after a gunshot wound in the head or other penetrating injury, according to a new study published in a recent online issue of Neurology. The tool is called the SPIN-Score, which stands for Surviving Penetrating Injury to the Brain.
In the ANSWER (Adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction) study of the PulseRider device (Pulsar Vascular), enrolment, 30-day and 180-day follow-up are complete for all 34 patients. At the moment, 365-day follow-up on eight patients is complete, and investigators are in the process of collecting these data on the remaining patients; which should be complete by the end of the year. Now, NeuroNews speaks to principal investigator Alejandro Spiotta (Medical University of South Carolina, USA) about his experience.
Medtronic has announced that it has notified customers of a voluntary recall of certain lots of its Pipeline embolization device, Alligator retrieval device and X-Celerator hydrophilic guidewire. The recall also includes the stylet containing UltraFlow flow directed micro catheters and Marathon flow directed micro catheters. These products are produced, marketed and sold by Medtronic’s Neurovascular business, which is part of the Brain Therapies division in the company’s Restorative Therapies Group.
A new study comparing acute damage to the arterial wall caused by ADAPT (a direct aspiration first pass technique) or stent retrievers during thrombectomy procedures has found that while both techniques caused acute damage to the vessel walls, thrombectomy with a stent retriever appeared to be more harmful to all layers of the arterial wall, particularly the endothelium.
Now that mechanical thrombectomy for the treatment of acute ischaemic stroke is on its way to becoming well-established practice, new devices are beginning to emerge. One such device is a new clot retriever technology—Ncap device from NOHA—which has thus far been tested in animal models.
There is no doubt now that mechanical thrombectomy has been established as the new standard of care for the treatment of emergent large vessel occlusion stroke. But moving forward, stroke teams around the world have begun to look for ways in which the process can be improved so that the treatment can reach as many patients as possible, as quickly as possible. To do this, increasing focus is being placed on improving the pathways of care.
In an analysis that included nearly 1,300 patients with large-vessel ischaemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other device to remove a blood clot) plus medical therapy (use of a clot dissolving agent) compared with medical therapy alone was associated with less disability at three months, according to a study appearing in the 27 September issue of JAMA.
The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischaemic stroke. This was recently proven by four randomised controlled trials (MR CLEAN, SWIFT-PRIME, EXTEND-IA, ESCAPE), in patients with a proximal large vessel occlusion. The ARTESp study, recently published by Sascha Prothmann, Department of Diagnostic and Interventional Neuroradiology at Klinikum rechts der Isar, et al, in the Journal of NeuroInterventional Surgery (JNIS) mirrors and reinforces the findings of the above mentioned trials.
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders
NIH-funded study suggests efforts to prevent risk factors should extend to those older than 65
Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. This research, supported by the National Institutes of Health, sheds light on how brain activity influences brain development, and highlights the newly found importance of the immune system in how the brain is wired, as well as how the brain forms new connections throughout life in response to change.
NIH-funded study could lead to new treatments for amblyopia.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos